Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content. If you have any issues relating to the topics here, please call the MS-UK Helpline on 0800 7830 518.


 

Data analysis of two previous trials has shown that a higher number of patients with relapsing remitting multiple sclerosis (RRMS) achieved no evidence of disease activity (NEDA), over a two year...

A case report has revealed that a patient who was treated with alemtuzumab (Lemtrada) contracted food poisoning. 

Although the female patient’s symptoms mimicked those of an infusion...

Less than a year after publishing research identifying a single genetic mutation that caused multiple sclerosis (MS) in two Canadian families, scientists at the University of British Columbia have...

Scientists have made another advance in finding a new potential treatment of MS by discovering a new way to alter the immune system without using chemotherapy.

In a mouse study a group of...

New research, involving mice, has shown that antibiotics used in very early life can alter the normal development of gut bacteria and may contribute to the development of a number of inflammatory...

MPs and patient groups are calling for an end to the repeated assessments that people with progressive diseases must undergo in order to qualify for disability benefits.

Due to changes in...

People with variants of two particular genes are three times more likely to develop multiple sclerosis (MS) according to findings from scientists at Duke Health and the University of Texas Medical...

Researchers from the University of Alberta have discovered an entirely new cellular mechanism, an underlying defect in brain cells, which may be to blame for the MS and a potential avenue of...

The US Food and Drug Administration (FDA) has approved Ocrevus, otherwise known as ocrelizumab, to treat adult patients with...

Israeli biotechnology company Kadimastem has been granted a United States patent for its technology used in stem cell treatment for multiple sclerosis (MS) and other neurodegenerative diseases....

Pages

Live Chat Software by Click4Assistance UK